ANI Pharmaceuticals, Inc. (ANIP), a prominent player in the healthcare sector, operates within the highly competitive drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. With a market capitalization of $1.69 billion, this Minnesota-based biopharmaceutical company has carved a niche for itself by developing, manufacturing, and marketing a diverse range of pharmaceutical products, including injectables, softgel capsules, and the well-known Cortrophin gel.

Currently trading at $75.10, ANI Pharmaceuticals has experienced a slight decline of 0.03%, but its price movement over the past 52 weeks—from a low of $54.51 to a high of $98.81—demonstrates its underlying volatility and potential for…